The Role of Surgery for Stage IV Melanoma.
Immunotherapy
Melanoma
Metastatectomy
Metastatic melanoma
Palliative resection
Journal
Advances in surgery
ISSN: 1878-0555
Titre abrégé: Adv Surg
Pays: United States
ID NLM: 0045335
Informations de publication
Date de publication:
Sep 2024
Sep 2024
Historique:
medline:
2
8
2024
pubmed:
2
8
2024
entrez:
1
8
2024
Statut:
ppublish
Résumé
Historically, stage IV melanoma carried a dismal prognosis and surgical resection was the only potential treatment offering long-term survival or palliation of symptomatic disease. With modern systemic therapies that can provide durable disease control for many patients with metastatic disease, we are actively redefining the role of surgery in metastatic melanoma. Contemporary treatment strategies can employ surgical resection in the upfront setting followed by adjuvant therapy, or used in tailored approach following systemic therapy. The combination of surgical resection and modern therapies has been associated with good long-term survival.
Identifiants
pubmed: 39089779
pii: S0065-3411(24)00013-7
doi: 10.1016/j.yasu.2024.04.013
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
223-234Informations de copyright
Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Disclosures Dr A.M. Dann has no disclosures. Dr C. Ariyan owns stock in Pfizer and sits on the ad board of Iovance and Merck.